Characteristics of bone turnover in the long bone metaphysis fractured patients with normal or low Bone Mineral Density (BMD)

Christoph Wölfl, Daniela Schweppenhäuser, Thorsten Gühring, Caner Takur, Bernd Höner, Ulrich Kneser, Paul Alfred Grützner, Leila Kolios, Christoph Wölfl, Daniela Schweppenhäuser, Thorsten Gühring, Caner Takur, Bernd Höner, Ulrich Kneser, Paul Alfred Grützner, Leila Kolios

Abstract

The incidence of osteoporotic fractures increases as our population ages. Until now, the exact biochemical processes that occur during the healing of metaphyseal fractures remain unclear. Diagnostic instruments that allow a dynamic insight into the fracture healing process are as yet unavailable. In the present matched pair analysis, we study the time course of the osteoanabolic markers bone specific alkaline phosphatase (BAP) and transforming growth factor β1 (TGFβ1), as well as the osteocatabolic markers crosslinked C-telopeptide of type-I-collagen (β-CTX) and serum band 5 tartrate-resistant acid phosphatase (TRAP5b), during the healing of fractures that have a low level of bone mineral density (BMD) compared with fractures that have a normal BMD. Between March 2007 and February 2009, 30 patients aged older than 50 years who suffered a metaphyseal fracture were included in our study. BMDs were verified by dual energy Xray absorptiometry (DXEA) scans. The levels of BTMs were examined over an 8-week period. Osteoanabolic BAP levels in those with low levels of BMD were significantly different from the BAP levels in those with normal BMD. BAP levels in the former group increased constantly, whereas the latter group showed an initial strong decrease in BAP followed by slowly rising values. Osteocatabolic β-CTX increased in the bone of the normal BMD group constantly, whereas these levels decreased significantly in the bone of the group with low BMD from the first week. TRAP5b was significantly reduced in the low level BMD group. With this work, we conduct first insights into the molecular biology of the fracture healing process in patients with low levels of BMD that explains the mechanism of its fracture healing. The results may be one reason for the reduced healing qualities in bones with low BMD.

Conflict of interest statement

Competing Interests: The authors have declared that no competing interests exist.

Figures

Figure 1. Course of BAP serum concentration…
Figure 1. Course of BAP serum concentration during fracture healing of eight weeks in low BMD versus normal BMD patients.
Statistics were performed using the software SPSS 11.0.0 (IBM Germany, Munich, Germany), P≤0.05 was considered to be significant, p≤0.01 as very significant, and p≤0.001 as highly significant. Different levels of significance are marked by one to three stars.
Figure 2. Course of TGFβ1 serum concentration…
Figure 2. Course of TGFβ1 serum concentration during fracture healing of eight weeks in low BMD versus normal BMD patients.
Statistics were performed using the software SPSS 11.0.0 (IBM Germany, Munich, Germany), P≤0.05 was considered to be significant, p≤0.01 as very significant, and p≤0.001 as highly significant. Different levels of significance are marked by one to three stars.
Figure 3. Course of CTX serum concentration…
Figure 3. Course of CTX serum concentration during fracture healing of eight weeks in low BMD versus normal BMD patients.
Statistics were performed using the software SPSS 11.0.0 (IBM Germany, Munich, Germany), P≤0.05 was considered to be significant, p≤0.01 as very significant, and p≤0.001 as highly significant. Different levels of significance are marked by one to three stars.
Figure 4. Course of TRAP5b serum concentration…
Figure 4. Course of TRAP5b serum concentration during fracture healing of eight weeks in low BMD versus normal BMD patients.
Statistics were performed using the software SPSS 11.0.0 (IBM Germany, Munich, Germany), P≤0.05 was considered to be significant, p≤0.01 as very significant, and p≤0.001 as highly significant. Different levels of significance are marked by one to three stars.
Figure 5. Consolidation of the fractures following…
Figure 5. Consolidation of the fractures following the Lane-Shandu-scoring after 4 and 8 weeks, assessed by two independent examiners.

References

    1. Ivaska KK, Gerdhem P, Akesson K, Garnero P, Obrant KJ (2007) Effect of Fracture on Bone Turnover Markers: A Longitudinal Study Comparing Marker Levels Before and After Injury in 113 Elderly Women. JBMR 22: 1155–64.
    1. Garnero P (2008) Biomarkers for osteoporosis management: utility in diagnosis, fracture risk prediction and therapy monitoring. Mol Diagn Ther 12: 157–70.
    1. Garnero P, Delmas PD (2004) Contribution of bone mineral density and bone turnover markers to the estimation of risk of osteoporotic fracture in postmenopausal women. J Musculoskelet Neuronal Interact 4: 50–63.
    1. Joerring S, Jensen LT, Andersen GR, Johansen JS (1992) Types I and III procollagen extension peptides in serum respond to fracture in humans. Arch Orthop Trauma Surg 111: 265–7.
    1. Joerring S, Krogsgaard M, Wilbek H, Jensen LT (1994) Collagen turnover after tibial fractures. Arch Orthop Trauma Surg 113: 334–6.
    1. Akesson K, Vergnaud P, Delmas PD, Obrant KJ (1995) Serum osteocalcin increases during fracture healing in elderly women with hip fracture. Bone 16: 427–30.
    1. Kurdy NM, Bowles S, Marsh DR, Davies A, France M (1998) Serology of collagen types I and III in normal healing of tibial shaft fractures. J Orthop Trauma 12: 122–6.
    1. Obrant KJ, Ivaska KK, Gerdhem P, Alatalo SL, Pettersson K (2005) Biochemical markers of bone turnover are influenced by recently sustained fracture. Bone 36: 786–92.
    1. Ingle BM, Hay SM, Bottjer HM, Eastell R (1999) Changes in bone mass and bone turnover following distal forearm fracture. Osteoporos Int 10: 399–407.
    1. Ingle BM, Hay SM, Bottjer HM, Eastell R (1999) Changes in bone mass and bone turnover following ankle fracture. Osteoporos Int 10: 408–15.
    1. Veitch SW, Findlay SC, Hamer AJ, Blumsohn A, Eastell R (2006) Changes in bone mass and bone turnover following tibial shaft fracture. Osteoporos Int 17: 364–72.
    1. Obrant KJ (1984) Trabecular bone changes in the greater trochanter after fracture of the femoral neck. Acta Orthop Scand 55: 78–82.
    1. Nyman MT, Paavolainen P, Forsius S, Lamberg-Allardt C (1991) Clinical evaluation of fracture healing by serum osteocalcin and alkaline phosphatase. Ann Chir Gynaecol 80: 289–93.
    1. Kurdy NM (2000) Serology of abnormal fracture healing: The role of PIIINP, PICP, and BsALP. J Orthop Trauma 14: 48–53.
    1. Heiss C, Hoesel LM, Pausch M, Meissner SA, Horas U, et al.. (2008) Biochemical bone resorption markers during the healing of osteoporotic fractures. Unfallchirurg 111: 695–702.
    1. Kanis JA, Johnell O, Oden A, Dawson A, De Laet C, et al.. (2001) Ten year probabilities of osteoporotic fractures according to BMD and diagnostic thresholds. Osteoporos Int 12: 989–95.
    1. Lill CA, Gerlach UV, Eckhardt C, Goldhahn J, Schneider E (2002) Bone changes due to glucocorticoid application in an ovariectomized animal model for fracture treatment in osteoporosis. Osteoporos Int 13: 407–14.
    1. Mallmin H, Ljunghall S, Larsson K (1993) Biochemical Markers of Bone Metabolism in Patients With Fracture of the Distal Forearm. Clin Orthop Rel Res 295: 259–63.
    1. Hoesel LM, Wehr U, Rambeck A, Schnettler R, Heiss C (2005) Biochemical Bone Markers Are Useful to Monitor Fracture Repair. Clin Orthop Rel Res 440: 226–32.
    1. Hoshino H, Takahashi M, Kushida K, Ohishi T, Inoue T (1998) Urinary excretion of type I collagen degradation products in healthy women and osteoporotic patients with vertebral and hip fractures. Calcif Tissue Int 62: 36–9.
    1. Sato Y, Kaji M, Higuchi F (2001) Changes in bone and calcium metabolism following hip fracture in elderly patients. Osteoporos Int 12: 445–9.
    1. Emami A, Larsson A, Petren-Mallmin M, Larsson S (1999) Serum bone markers after intramedullary fixed tibial fractures. Clin Orthop Relat Res 368: 220–9.
    1. Ohishi T, Takahashi M, Kushida K (1998) Changes of biochemical markers during fracture healing. Arch Orthop Trauma Surg 118: 126–30.
    1. Bostrom MPG, Asnis P (1998) Transforming growth factor in fracture repair. Clin. Orthop. Rel. Res 355: 124–131.
    1. Rosier RN, O’Keefe RJ, Hicks DG (1998) The potential role of transforming growth factor in fracture healing. Clin. Orthop. Rel. Res 355: 294–300.
    1. Kolios L, Hitzler M, Moghaddam A, Takur C, Schmidt‑Gayk H, Höner B, Lehnhardt M, Grützner P, Wölf C. (2012) Characteristics of bone metabolism markers during the healing of osteoporotic versus nonosteoporotic metaphyseal long bone fractures: a matched pair analysis. European Journal of Trauma and Emergency Surgery. 10.1007/s00068-012-0190-1
    1. Kolios L, Hitzler M, Moghaddam A, Takur C, Schmidt‑Gayk H, Höner B, Lehnhardt M, Grützner P, Wölf C. (2020) Correction to: Characteristics of bone metabolism markers during the healing of osteoporotic versus nonosteoporotic metaphyseal long bone fractures: a matched pair analysis. European Journal of Trauma and Emergency Surgery. 10.1007/s00068-020-01385-2

Source: PubMed

3
Abonnieren